Hyperkalemia

Hyperkalemia Events Common With RAAS Inhibitor Use in CKD

Publish Date March 13, 2019

Almost half of incident hyperkalemia events are followed by changes in RAAS inhibitor therapy.

Spironolactone Has No Effect on LVM in Hemodialysis Patients

Publish Date February 7, 2019

Patients treated with the mineralocorticoid receptor antagonist had a higher frequency of moderate hyperkalemia compared with placebo recipients.

Hyperkalemia Worsens Outcomes in Elderly Patients Hospitalized for HF

Publish Date February 11, 2019

Elderly patients hospitalized for heart failure who have high serum potassium levels at admission are at increased risk of readmission for heart failure and death.

Sustained Normokalemia to Enable RAAS Inhibition Beneficial in CKD

Publish Date February 5, 2019

New model predicts that maintenance of normal potassium levels in CKD patients to optimize use of renin-angiotensin-aldosterone inhibitors can delay progression to ESRD and prolong survival.

Hyperkalemia Link With Brugada Syndrome ECG Characterized

Publish Date February 1, 2019

In patients with severe hyperkalemia, the Brugada syndrome ECG phenotype is associated with a high prevalence of malignant arrhythmias and all-cause mortality.

Parathyroidectomy-Associated Hyperkalemia Common in HD Patients

Publish Date January 22, 2019

Hyperkalemia developed in nearly 67% of hemodialysis patients during or immediately following total parathyroidectomy with autotransplantation for secondary hyperparathyroidism.

Spironolactone Helps HF Patients With CKD, But Ups Hyperkalemia Risk

Publish Date January 8, 2019

Spironolactone improved cardiovascular outcomes in heart failure patients with chronic kidney disease, but increased their risk of hyperkalemia.

Hyperkalemia Increases Risk for Progression to ESRD

Publish Date January 2, 2019

Elevated serum potassium levels increased the risk for end-stage renal disease by approximately 30%, independent of decline in estimated glomerular filtration rate.

Dyskalemia Common in Heart Failure

Publish Date December 24, 2018

Sex, high and low baseline potassium levels, and reduced renal function independently predict hyper- and hypokalemia in patients with heart failure.

Hyperkalemia Drug May Act as Phosphate Binder

Publish Date October 26, 2018

In a study, patiromer lowered serum phosphate in patients with hyperkalemia and hyperphosphatemia.